Antoni Duleba

Trials

Studies that name Antoni Duleba as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:47 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT07092527 · Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

  University of California, San Diego · recruiting · Transgenderism, Reproductive Issues · principal investigator
• Ph4
  NCT06450405 · Androgen Effects on the Reproductive Neuroendocrine Axis

  University of California, San Diego · terminated · Transgenderism, Reproductive Issues · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 02:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Mevalonate pathway and thecal-interstitial function
  R01HD050656 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2007 to 2011 · $300,840 awarded in 2011
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Androgen effects on the reproductive neuroendocrine axis
  R01HD111650 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALEXANDER S KAUFFMAN · fiscal years 2024 to 2026
  Named on NCT07092527, NCT06450405